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ClinicalMethodA Successful Approach to Kidney Transplantation
in PatientsWith Enteric (Secondary) Hyperoxaluria
Joke I. Roodnat, MD, PhD,1 Anneke M. E. de Mik-van Egmond,2 Wesley J. Visser,2 Stefan P. Berger, MD, PhD,3
Wilbert A. G. van der Meijden, MD,4 Felix Knauf, MD,5 Madelon van Agteren, MD,1 Michiel G.H. Betjes, MD, PhD,1
and Ewout J. Hoorn, MD, PhD1Background. Enteric hyperoxaluria due to malabsorption may cause chronic oxalate nephropathy and lead to end-stage
renal disease. Kidney transplantation is challenging given the risk of recurrent calcium-oxalate deposition and nephrolithiasis.
Methods.We established a protocol to reduce plasma oxalic acid levels peritransplantation based on reduced intake and
increased removal of oxalate. The outcomes of 10 kidney transplantation patients using this protocol are reported.Results.
Five patients received a living donor kidney and had immediate graft function. Five received a deceased donor kidney and
had immediate (n = 1) or delayed graft function (n = 4). In patients with delayed graft function, the protocol was prolonged
after transplantation. In 3 patients, our protocol was reinstituted because of late complications affecting graft function.
One patient with high-output stoma and relatively low oxalate levels had lost her first kidney transplant because of recurrent
oxalate depositions but now receives intravenous fluid at home on a routine basis 3 times per week to prevent dehydration.
Patients are currently between 3 and 32 months after transplantation and all have a stable estimated glomerular filtration rate
(mean, 51 ± 21 mL/min per 1.73 m2). In 4 of 8 patients who underwent for cause biopsies after transplantation oxalate de-
positions were found.Conclusions. This is the first systematic description of kidney transplantation in a cohort of patients
with enteric hyperoxaluria. Common complications after kidney transplantation impact long-term transplant function in these pa-
tients. With our protocol, kidney transplantation outcomes were favorable in this population with unfavorable transplantation pros-
pects and even previous unsuccessful transplants.
(Transplantation Direct 2017;3: e331; doi: 10.1097/TXD.0000000000000748. Published online 8 November, 2017.)Secondary or enteric hyperoxalemia leading to hyper-oxaluria can be caused by several disorders including
short-bowel syndrome,1 pancreatic insufficiency,2 gastric by-
pass surgery,3-5 cystic fibrosis,6 and celiac disease.7 The com-
mon denominator in these disorders is fat malabsorption.Received 5 August 2017. Revision requested 22 September 2017.
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2 Transplantation DIRECT ■ 2017 www.transplantationdirect.comcolon. Therefore, patientswithmalabsorption but with intact
colons are particularly prone to high oxalic acid levels.8 As
oxalic acid is eliminated by the kidney, another cause of high
oxalic acid levels is chronic kidney disease.10 Conversely,
high concentrations of oxalic acid in combination with high
calcium levels in the urine may cause calcium-oxalate deposi-
tion and stones. Treatment of patients with enteric hyper-
oxaluria with kidney stones and/or deteriorating kidney
function should rely on restriction of oxalic acid intake, and
avoidance of dehydration.11 Dietary oxalic acid intake varies
between 200 and 400 mg with excessive intakes up to 600 to
800 mg per day. Dietitians usually recommend avoiding
oxalic acid rich foods, eg rhubarb (541 mg/125 g), spinach
(755mg/125 g), and almonds (122 mg per handful). This ad-
vice was not successful in patients with gastric bypasses.12 In
addition, patients are usually allowed to continue drinking
tea, which contains 14 mg per cup and may, even in healthy
individuals, lead to enteric hyperoxaluria and renal function
decline when intake is excessive.13 A diet limiting intake of
oxalic acid to 30 to 50mg per daywas shown to reduce urine
oxalate in patients with enteric hyperoxaluria.14
When native kidney function is lost because of enteric
hyperoxaluria, it is even more difficult to preserve transplanted
kidney function because the recurrence rate of calcium-
oxalate crystal deposition and kidney stones is high, espe-
cially when no adequate measures are taken to decrease
plasma and urine oxalic acid concentrations.15 Recently, a
review on the pathophysiology and scarce literature on ther-
apy showed that there is no consensus on treatment of enteric
hyperoxaluria.16 We developed a protocol based on lowering
plasma oxalic acid levels before and immediately after trans-
plantation to lower the risk of recurrence (Table 1). We report
our preliminary experience with this protocol in 10 patients
with hyperoxaluria who underwent kidney transplantation.PATIENTS AND RESULTS
Between January 2014 and January 2016, 17 (3%) of
611 patients that presented for prekidney transplant evalua-
tion had enteric hyperoxaluria. Six of these patients opted
for a retransplant. Earlier transplantations had been per-
formed before the implementation of the oxalate lowering
protocol, and all but 1 transplants failed (0, 18 months, 2TABLE 1.







Low-oxalic acid diet (40-50 mg/day)a Oxalic acid-free drip-feed
Cholestyramine (3 times 4 g) Daily 6-h hemodialysis
sessionsb
Sodium bicarbonate (3 times 500-1000 mg)
Calcium carbonate (3 times 500 mg during meals)
a https://regepi.bwh.harvard.edu/health/Oxalate/files.
b Other settings: high flux membrane (2.2 m2), Qb 350 mL/min, bicarbonate 28 to 30 mmol/L, calcium 1
c Standard immunosuppressive regimen in our center is basiliximab induction, tacrolimus, mycophenolateand 3 years and 8 years after transplantation). The latter is
5 years after transplantation and used an oxalic acid limited
diet on his own initiative since transplantation (present esti-
mated glomerular filtration rate [eGFR], 20 mL/min). In all
6 patients, oxalate depositions were shown in the biopsy.
Only 3 of 17 patients (2 with a former transplant) received
nutritional counseling regarding prevention of hyperoxaluria
before referral for transplantation.
Our center specializes in complex transplantation prob-
lems as part of our academic center of excellence.18 Though
challenging, after conscientious preparations and approval,
well-informed and consenting secondary hyperoxaluria patients
were accepted for transplantation. From the 17 patients with
enteric hyperoxaluria 4 patients decided not to proceed with
retransplantation because of fear of complications. One pa-
tient is currently awaiting kidney transplantation. Two pa-
tients have been prepared and are keeping low oxalic acid
diet, but they TEMPORARILY are on a nontransplantable
urgency because of comorbidity. Ten patients have been
transplanted and are reported in more detail below and in
Table 2. In 6 of the 10 transplanted patients with enteric
hyperoxaluria, oxalate nephropathy or stones were identi-
fied in native or in former transplant kidneys, whereas in
the remaining patients, enteric hyperoxaluria was considered
probable, but not proven (patients 4, 8, 9, and 10).
Plasma oxalic acid levels were measured in these patients
by capillary gas chromatography with amethodmodified ac-
cording to Wolthers (upper normal level, 5 μmol/L).19 Sam-
ples were taken during the patients' visit to the outpatient
department (oxalic acid before diet) and pretransplantation.
Oxalate concentration in 24-hour urine was measured enzy-
matically. Stone formation is probable above a urinary concen-
tration of 0.5 mmol/L. Although all patients had elevated
plasmaoxalic acid levels, this level clearly depended on the pres-
ence of an intact colon: patients with complete colon in con-
tinuity with small bowel having the highest levels (Figure 1).
Preparations in patients with secondary hyperoxaluria
(Table 1): A period of 6 months was used to introduce and
acquaint patients with the low oxalic acid diet. In addition,
patients were treated with calcium supplementation during
meals (to bind oxalic acid in the gut), cholestyramine (to bind
fatty acids in the gut), and sodium bicarbonate (Table 1). The
latter is used to increase urinary pH, thereby diminishingDirect posttransplantation period




Stop drip-feed, start low-oxalic
acid diet
Standard immunosuppressive regimenc Stop hemodialysis
No loop diuretics Sufficient fluid intake to maintain









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































© 2017 Wolters Kluwer Roodnat et al 3
FIGURE 1. Plasma oxalic acid levels in eighteen patients with hyper-
oxaluria divided into 4 groups: group 1: Six patients with intact colon,
including patients with chronic pancreatitis (1 patient), gastric bypass
(1 patient), and Crohn’s disease requiring short bowel resections
(4 patients); group 2: Six patients with partial colectomy, including
patients with resections for Crohn’s disease who underwent partial
colectomy (5 patients) or resections because of encapsulating perito-
neal sclerosis (one patient); group 3: Five patients without a functional
colon, including patients with ileostomy because of resections for
Crohn’s disease (4 patients) or small bowel perforation (1 patient);
group 4: One patient with primary hyperoxaluria. * Patient not on di-































































































































































































































































































































































































































































4 Transplantation DIRECT ■ 2017 www.transplantationdirect.comthe uptake of filtered citrate by the proximal tubular cells and
raising urinary citrate excretion. All patients suffered from
diarrhea or loose stools. With dietary advice, both volume
and frequency of diarrhea were reduced. All group 3 patients
presented with stoma production of about 2 L per day.
Through intensive counseling by our dietician this volume
could be reduced to about 1200 mL. In recipients of a living
donor transplantation, protocol started 1 week before
transplantation with intensive hemodialysis (IHD) (6 days,
6 hours) and oxalic acid-free drip feed. In recipients of a
deceased donor kidney, drip feed and IHD were started at
transplantation. Independent of donor type, IHD and drip
feed were continued until kidney function was adequate
and urine production was more than 2 L per day. Loop
diuretics were prohibited as they cause hypercalciuria that
may promote calcium oxalate formation in the kidney.
After transplantation, low oxalic acid diet was continued
and oxalic acid levels in plasma and urine as well as citrate,
calcium and magnesium in urine were determined.
Cases Transplanted According to Protocol
Patient 1was on hemodialysis for 7 years when he was re-
ferred to our center for second opinion, after being declined
because of enteric hyperoxaluria and recurrent D-lactate aci-
dosis. Two months after transplantation he was readmitted
because of Escherichia coli pneumonia with sepsis and an-
uria. Mycophenolate mofetil (MMF) was stopped, the dose
of prednisone was decreased and protocol was reinstituted.
Figure 2 shows how serum creatinine and plasma oxalic acid
levels drop sharply before transplantation and remain low
until sepsis intervenes at month 2 (see Table 2 for details).
Patient 2 lost his first malfunctioning renal transplant after
18 months, the biopsy showed oxalate deposition. His sec-
ond kidney transplantation was uneventful. From 6 months
FIGURE 2. Development of serum creatinine and plasma oxalic acid
levels after LD transplantation in patient 1. Levels dropped sharply
before transplantation and remained low until sepsis intervened at
month 2 when protocol was reinstituted.
FIGURE 4. Development of serum creatinine and plasma oxalic acid
levels after DD transplantation in patient 3. Because of DGF protocol
was continued after transplantation. When renal function improved,
oxalic acid levels remain low after transplantation but increase parallel
to creatinine during her urinary tract infection with hydronephrosis.
© 2017 Wolters Kluwer Roodnat et al 5after transplantation onward, he suffered from passing native
kidney stones and urinary tract infections. Ultrasonography
did not show stones or calcification in the transplanted kid-
ney. Although plasma and urine oxalic acid levels remained
low, his kidney function slowly deteriorated with each epi-
sode of infection. After urological intervention, actively re-
moving native kidney stones combined with long-term
antibiotic treatment his renal function improved and stabi-
lized. Serum creatinine and plasma oxalic acid levels are
shown in Figure 3. (see Table 2 for details).
Patient 3 had delayed graft function but, at discharge, her
eGFR was 47 mL/min. Because of low levels, weekly magne-
sium administrations at homewere started on a routine basis.
Six months after transplantation, she suddenly developed
hydronephrosis caused by stenosis of the ureter-bladder
anastomosis. A nephrostomy drain was inserted. A kidney
biopsy only showed signs of a urinary tract infection and
2 small oxalate crystals but no rejection. After treatment of
the urinary tract infection, the nephrostomy drain could be
removed and serum creatinine returned to baseline value. Se-
rum creatinine and oxalic acid levels are shown in Figure 4.
(see Table 2 for details).
Patient 4 had lost 36 kg after his gastric bypass, but his
kidney function deteriorated progressively and hemodialysis
had to be started. He was referred for second opinion after
being turned down for transplantation in his own centerFIGURE 3. Development of serum creatinine and plasma oxalic acid
levels after LD transplantation in patient 2. Serum creatinine rose with
recurrent urinary tract infections, oxalic acid levels increase slightly.
Renal function and oxalic acid levels stabilized after infections were
controlled.because of perceived high risk. Transplantation was compli-
cated by bleeding and vascular reconstructions (see Table 2
for details).
Patient 5 lost her first renal transplant after 8 years because
of chronic allograft nephropathy with oxalate crystal deposi-
tion. Her second DCD kidney transplantation was compli-
cated by short-term delayed graft function (DGF) for 2 days
and thrombotic microangiopathy (see Table 2 for details).
Patient 6 had a high-output ileostomy that produced 1.5
to 2 L per day. In 2011 she received a first kidney transplan-
tation from her brother. High stoma production (2 L/day) de-
creased urine output and kidney function deteriorated
quickly. A Noro virus infection with diarrhea caused perma-
nent loss of graft function at 3 years after transplantation.
The renal biopsy showed oxalate crystals from 1 year on-
ward. In preparation for the next transplantation, shewas in-
tensively coached by dieticians to decrease stoma production
(maximally 100 mL drinking during meals, no hypo- or hy-
pertonic fluids, only isotonic fluids, fluid intake in small por-
tions divided over the day, extra NaCl during meals). With
that regimen stoma output decreased to 1.2 L/day. A second
living donor (LD) kidney transplantation was performed
with a kidney from her niece. Standard thrice weekly hemo-
dialysis instead of daily hemodialysis (because of low oxalic
acid levels) was combined with oxalic-acid-free drip feed.
Transplantation was uneventful and stoma output remained
stable at 1.2 L per day. However, with oral intake of 3 L per
day urine production stabilized at 1.4 L/day and eGFR de-
creased, especially on warm days to 20 ml/min. Intravenous
(IV) fluid (2 L) andmagnesium administrations at homewere
started on a routine basis for 3 nights per week. Since then re-
nal function improved and stabilized (see Table 2 for details).
Patient 7 was treated with external shock wave lithotripsy
to reduce calcium oxalate kidney stone load as much as pos-
sible to prevent stone related complications posttransplanta-
tion. Because there was no adequate transplant function, the
protocol was continued after transplantation, but at the pa-
tient’s request, hemodialysis was decreased to 3 times per
week 6 hours and gastric tube and drip feed were replaced
by low oxalic acid diet. He suffered from recurrent urinary
tract infections and hydronephrosis. After removal of native
kidney ureter stones and ureter-bladder re-anastomosis at
8 months after transplantation, his renal function improved
and stabilized (see Table 2 for details).
6 Transplantation DIRECT ■ 2017 www.transplantationdirect.comPatient 8 had been declined for transplantation by another
transplantation center because of recurrent chronic pancreatitis.
At presentation her plasma oxalic acid level was 89 μmol/L. She
did not use her pancreatic enzyme supplementation. En-
zyme supplements were restarted, and pancreatic outflow
was improved to extinguish bouts of pancreatitis. Besides,
low oxalic acid diet was started. Tacrolimus and mycophe-
nolic acid test doses were tried that did not provoke pancre-
atitis. Transplantation was uneventful, but urinary leakage
was observed and a percutaneous nephrostomy (PCN) was
introduced and moved into the bladder. After healing up of
the defect in ureter bladder anastomosis the PCN could be
removed. Since then, eGFR stabilized. She did not develop
pancreatitis (see Table 2 for details).
Patient 9 started his low oxalic acid diet 1 year before his
uneventful DCD renal transplantation. At day 6, he devel-
oped ileus caused by a known stenotic trajectory in the
neoterminal ileum. With conservative treatment ileus sub-
sided and feeding could be restarted. Renal function re-
mained stable.
Patient 10 had extensive comorbidity. Apart from general
measures, pretransplant preparations comprised dietary re-
strictions to decrease stoma production from 2 L to 1.2 L.
Oneweek before transplantation, daily hemodialysis sessions
were combinedwith low oxalic acid diet on patients' request.
He received an LD renal transplantation with direct function.
However, from day 1 onward, renal function and generalTABLE 3.
Literature: case reports on kidney transplantation in patients wit




of ESRD Donor type
19 65 y, M Short bowel CaOx DD
20 62 y, F Short bowel CaOx stones DD











22 74 y, M Short bowel CaOx stones N.R.
23 40 y, M Short bowel CaOx stones DD
24 60 y, M Short bowel Renal stones DD
25 70 y, M Chronic pancreatitis Diabetic
nepropathy
DD






7 57 y, F Celiac disease CaOx LD
27 70 y, M Gastric bypass N.R. DD
27 67 y, M Gastric bypass CaOx stones DD
28 56 y, F Short bowel CaOx stones DD
28 41 y, F Short bowel CaOx stones DD
16 38 y, F Short bowel CaOx stones LD
16 39 y, F Short bowel CaOx stones LD 2nd
transplant
16 48 y, M Short bowel CaOx stones DD
16 47 y, F Short bowel CaOx stones DD
3w, thrice weekly; Ca, calcium supplementation; ESRD, end-stage renal disease; DD, deceased donor; HDcondition deteriorated. Daily hemodialysis sessions and low
oxalic acid diet were continued. He developed erysipelas of
his right leg. Ongoing E. coli sepsis intervened, probably bile
tree derived, and he developedmultiorgan failure. He died on
day 14 after transplantation (see Table 2 for details).DISCUSSION
We report 10 consecutive patients with enteric hyper-
oxaluria in whom a protocol aimed at reducing plasma
oxalic acid levels resulted in favorable short-term outcomes
after kidney transplantation in 9 of them (Table 1). Patient
10 died at day 14 because of complications unrelated to
enteric hyperoxaluria. Although intensive monitoring and
support is necessary for these patients to maintain a low
oxalic acid diet (40-50 mg/day), all patients reported to
adhere to their diet, denied gastrointestinal complaints, and
maintained stable body weight. Drip feed and daily dialysis
sessions were experienced as burdensome by the patients,
but in our experience, and that of the patients, it is
compensated for by the final success. All patients with LD
transplantation were treated with low oxalic acid diet
followed by IHD and 4 of 5 patients with oxalic-acid-free
drip feed. Pretransplantation oxalic acid levels had decreased
considerably in all of them, and graft function was immediate
(Table 2). Four of 5 patients with a DD transplantation were







Diet, Ca No N.D. No 10 mo
Diet, Ca, citrate,
daily HD
17 d CaOx No 7 y
3w HD NFG CaOx Yes 7 mo
3w HD. After 18 mo:
start lipase, Ca
11 mo CaOx No 3 y
After recurrence
high urine volume
N.R. CaOx No 3 y
Daily HD 2 wk CaOx Yes 10 mo
Diet, Ca, K, citrate No No CaOx No 3 y
None No CaOx Yes 8 y
After 6 mo
MMF stopped
No CaOx Yes 8 mo
After 14 wk
gluten restriction
No CaOx No 7 mo
After 1 y diet, Ca No CaOx No 14 mo
None 1 mo CaOx Yes 11 mo
Small bowel transplantation No N.D. No 67 mo
Small bowel transplantation No N.D. No 11 mo
Ca, K, citrate, No CaOx Yes 6 y
Ca, citrate, loperamide,
pancreatic enzymes
No N.D. No 1 y
N.R. No N.D. No 3 y
N.R. No CaOx Yes 2 y
, hemodialysis; K, potassium supplementation; N.D., not determined; N.R., not reported.
© 2017 Wolters Kluwer Roodnat et al 7strict because time to transplantation was uncertain.
Decrease in oxalic acid levels was less pronounced and 3 of
5 patients were treated with IHD and drip feed after
transplantation. Patient 7 had the least strict treatment, and
he needed most time for recovery of the kidney, suggesting
that the intensity of the program did influence results. It is
not certain however whether IHD or oxalic acid free drip
feed alone would have had the same effect.
As shown in the recipients of an LD transplantation,
plasma oxalic acid levels could be decreased adequately after
intensive treatment. A directly functioning kidney transplant
decreased levels even further, reaching near normal levels
within a few days. However, without a functioning trans-
plant, oxalic acid levels increased parallel with increasing se-
rum creatinine values.
Despite malabsorption, tacrolimus levels were adequate in
all patients. In 2 patients, mycophenolic acid through levels
were low but area under the curves were adequate.
Our aim to maintain urinary output above 2 L/day seems
low regarding the risk for recurrence of oxalate depositions.
However, these patients lose fluid via diarrhea or via their
high-output stoma, decreasing urinary production. A fluid
intake above 3 L per day is hardly feasible for these patients
especially because high oral fluid volumes often trigger diar-
rhea and increase stoma production. When dehydration is
suspected, we typically give a trial of IV fluid during admis-
sion. When kidney function improves, IV fluid administra-
tion at home on a regular basis may be an option (patient 6).
Although surgery for Crohn’s disease or gastric bypass and
other reasons for malabsorption are quite common, the current
literature on kidney transplantation in patients with secondary
hyperoxaluria is limited to 12 articles covering 16 patients with
18 kidney transplantations7,16,20-29 (Table 3). In 2 years, we
gathered 17 patients with enteric hyperoxaluria showing that
it is more prevalent than expected. One possible explanation
for the relatively low number of reported cases may be that
enteric hyperoxaluria is underrecognized. Indeed, in 6 of the
previously reported patients, enteric hyperoxaluria was only
considered sometime after transplantation7,22,26-28 (Table 1).
Apart from the 2 patients with short bowel transplantation,
only 6 of 18 patients had been treated with diet or
medication or IHD in the direct postoperative phase. In
our 17 patients with enteric hyperoxaluria (Figure 1),
only 3 patients had nutritional counseling regarding
prevention of oxalate nephropathy before referral for
transplantation. This suggests that patients with secondary
hyperoxaluria were not optimally treated during the phase
their native kidney function deteriorated. This may have
contributed not only to accelerated native function decline
but also to increased risk of systemic oxalosis.30,31 Because
most patients with hyperoxaluria are primarily seen by
gastroenterologists and urologists, kidney function decline
may have progressed unnoticed for some time. Another
reason for underreporting may be that poor outcomes have
not been reported (publication bias) or patients with
secondary hyperoxaluria may have been declined for
kidney transplantation because of the high recurrence rate.
Actually, 3 of our 10 transplanted patients had been declined
for transplantation in other transplantation centers in The
Netherlands (patients 1, 4, and 8).
In our population, the highest oxalic acid levels were
found in group 1 with intact colon in continuity with smallbowel. Though levels tend to be lower in the population
without a colon (group 3) variability was high (Figure 1).
Despite currently low levels, patient 6 had lost her first
kidney transplant because of oxalate deposition. The reason
probably is that urine oxalic acid levels were high because
of low urine volume, but plasma levels may also have been
higher at that time. In patients with ileostomy, stones
contain both uric acid and calcium oxalate.32 For group
3 patients, the main purpose of treatment is to keep urine
volume as high as possible while keeping plasma oxalic
acid levels low according to our protocol.
Even long-term functioning kidney transplants may expe-
rience a “second hit” that disturbs oxalic acid homeostasis
and results in (temporary) loss of function.26 This “second
hit” may be an infectious gastroenteritis, symptomatic kid-
ney stones, sepsis with anuria, inadequate pancreatic enzyme
supplementation, decreased fluid intake or increased fluid
loss, or rejection of the transplant. Slow recovery (11months)
of graft function in a patient with enteric hyperoxaluria has
been reported previously.22 In 4 patients our protocol was
prolonged after transplantation (patients 3, 4, 5, 7), whereas
the protocol was reinstituted in 3 patients with a second hit
(patients 1, 4, 10). In 5 other patients with compromised re-
nal function, direct anticipation with fluid administration re-
sulted in improved urine output and decreasing serum
creatinine (patients 2, 3, 6, 7, 9). Patient 6 still receives IV
fluid administration 3 times per week to prevent dehydra-
tion. In patient 10, IHD was continued until it became
clear that the prognosis was very unfavorable because
of ongoing sepsis and multi organ failure unrelated to
hyperoxaluria.
This population is vulnerable because most of them suffer
from serious comorbidity threatening overall survival. Be-
sides, a sudden decrease in kidney function causes oxalate de-
position that results in potentially irreversible damage
threatening graft function.
Though urine oxalate levels have been measured at a regu-
lar basis, posttransplant data regarding urinary calcium,
and citrate excretions are incomplete. Although we only
describe 10 patients of whom 3 with follow-up of more
than 2 years, we feel that the strength of our protocol is
the favorable short-term results, even in the patients with
DGF and after recurrence of oxalate deposition. Com-
pared with the existing literature, our study is the largest
and first systematic description of kidney transplanta-
tion in a cohort of patients with enteric hyperoxaluria. In
an ongoing study, we found oxalate deposition within
3 months after transplantation in 17% of the patients
(without enteric hyperoxaluria) with for cause renal biopsy.
Follow-up biopsies became negative for oxalate deposition
suggesting reversibility of deposition in certain cases. Most
probably, depositions may wax and wane depending on the
oxalic acid load. Irreversible kidney function decline may re-
sult from excessive oxalic acid loads when crystals have per-
manently damaged kidney structure.
In conclusion, enteric, secondary hyperoxaluria is an
underestimated cause of kidney function decline in native
and transplanted kidneys. A protocol to decrease plasma
oxalic acid levels and increase urinary volume is feasible
and may be considered to prevent the occurrence of oxalate
nephropathy in native kidneys and recurrence and subse-
quent graft failure after transplantation.
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